Просмотренные публикации

QR-код этой страницы

Для продолжения изучения на мобильном устройстве ПРОСКАНИРУЙТЕ QR-код с помощью спец. программы или фотокамеры мобильного устройства

Случайный выбор

данная функция, случайным образом выбирает информацию для Вашего изучения,
запустите выбор нажав кнопку ниже

Обратная связь
Напишите нам

Поделитесь своими идеями по улучшению нашей работы.
Прикрепить файл или скриншот удалить
Закрытая часть портала предназначена для только для работников здравоохранения. Оставив свой e-mail и специалищацию, Вы подтверждаете, что являетесь работником здравоохранения и что Вы ознакомились с текстом и поняли его.


Сообщение об ошибке
Что улучшить?

Поделитесь своими идеями по улучшению нашей работы.
Прикрепить файл или скриншот удалить
Закрытая часть портала предназначена для только для работников здравоохранения. Оставив свой e-mail и специалищацию, Вы подтверждаете, что являетесь работником здравоохранения и что Вы ознакомились с текстом и поняли его.


Главная Статьи Приложение №1 к статье «Коллегиальное обсуждение формирования информированного добровольного согласия Ассоциации врачей-экспертов качества медицинской помощи по осложнениям и нежелательным явлениям при диагностических и лечебных эндо вмешательств

Статьи: Приложение №1 к статье «Коллегиальное обсуждение формирования информированного добровольного согласия Ассоциации врачей-экспертов качества медицинской помощи по осложнениям и нежелательным явлениям при диагностических и лечебных эндо вмешательств

Полный текст статьи:


ПРИЛОЖЕНИЕ №1 к статье «Коллегиальное обсуждение формирования информированного добровольного согласия Ассоциации врачей-экспертов качества медицинской помощи по осложнениям и нежелательным явлениям при диагностических и лечебных эндоскопических вмешательствах на верхних отделах желудочно-кишечного тракта» для журнала «Клиническая эндоскопия», 2024г


Публикация в разработке.


Список литературы (нажмите по галочке правее, чтобы раскрыть список)


1. Бурдюков М.С., Ватолин В.М., Петров С.П., Гусев Д.В., Кашин С.В., Королев В.Н., Кузин М.Н., Макаров С.Н., Неустроев В.Г., Никонов Е.Л., Приходченко А.О., Росанова Т.А., Дмитриенко Г.П. Основные результаты практического семинара «Экспертиза качества медицинской помощи. Информированное добровольное согласие пациента: эндоскопия». Доказательная гастроэнтерология. 2020;9(4):102-110. https://doi.org/10.17116/dokgastro20209041102]
2. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P. Endoscopic complications. Results of the 1974 American Society of Gastrointestinal Endoscopy Survey. JAMA 1976; 235(9):928–30.
3. Zubarik R, Eisen G, Mastropietro C, et al. Prospective analysis of complications 30 days after outpatient upper endoscopy. Am. J. Gastroenterol. 1999;94(6):1539–45.
4. Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society for Gastrointestinal Endoscopy/US Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest. Endosc. 1991;37(4):421–7.
5. Bell GD. Review article: Premedication and intravenous sedation for upper gastrointestinal endoscopy. Aliment. Pharmacol. Ther. 1990;4(2):103–22.
6. Sieg A, Hachmoeller-Eisenbach U, et al. Prospective evaluation of complications in outpatient GI endoscopy: a surveyamongGerman gastroenterologists. Gastrointest Endosc 2001;53:620-7.
7. Sharma VK, Nguyen CC, Crowell MD, et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 2007;66:27-34.
8. Heuss LT, Froehlich F, Beglinger C. Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland. Endoscopy 2005;37:161-6.
9. Gangi S, Saidi F, Patel K, et al. Cardiovascular complications after GI endoscopy: occurrence and risks in a large hospital system. Gastrointest Endosc 2004;60:679-85.
10. Clarke GA, Jacobson BC, Hammett RJ, et al. The indications, utilization and safety of gastrointestinal endoscopy in an extremely elderly patient cohort. Endoscopy 2001;33:580-4.
11. Lee JG, Leung JW, Cotton PB. Acute cardiovascular complications of endoscopy: prevalence and clinical characteristics. Dig. Dis. 1995;13(2):130–5.
12. Fleischer D. Monitoring the patient receiving conscious sedation for gastrointestinal endoscopy: issues and guidelines. Gastrointest. Endosc. 1989;35(3):262–6.
13. Sharma VK, Nguyen CC, Crowell MD, et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 2007;66:27-34.
14. Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71:446-54.
15. Griffin SM, Chung SC, Leung JW, et al. Effect of intranasal oxygen on hypoxia and tachycardia during endoscopic cholangiopancreatography. BMJ 1990;300:83-4.
16. Quine MA, Bell GD, McCloy RF, et al. Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg 1995;82:530-3.
17. Schulze S, Móller Pedersen V, Hóier-Madsen K. Iatrogenic perforation of the esophagus. Causes and management. Acta Chir Scand 1982;148: 679-82.
18. Pettersson G, Larsson S, Gatzinsky P, et al. Differentiated treatment of intrathoracic oesophageal perforations. Scand J Thorac Cardiovasc Surg 1981;15:321-4.
19. Vogel SB, Rout WR, Martin TD, et al. Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality. Ann Surg 2005;241:1016-21; discussion 1021-3.
20. Eroglu A, Turkyilmaz A, Aydin Y, et al. Current management of esophageal perforation: 20 years experience. Dis Esophagus 2009;22:374-80.
21. Abbas G, Schuchert MJ, Pettiford BL, et al. Contemporaneous management of esophageal perforation. Surgery 2009;146:749-55.
22. Anderson MA, Ben-Menachem T, Gan SI, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009;70:1060-70.
23. Montalvo RD, Lee M. Retrospective analysis of iatrogenic Mallory-Weiss tears occurring during upper gastrointestinal endoscopy. Hepatogastroenterology 1996;43:174-7.
24. Van Os EC, Kamath PS, Gostout CJ, et al. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc 1999;50:536-43.
25. Rebulla P. Revisitation of the clinical indications for the transfusion of platelet concentrates. Rev Clin Exp Hematol 2001;5:288-310.
26. Samama CM, Djoudi R, Lecompte T, et al. Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003. Can J Anaesth 2005;52: 30-7.
27. British Society of Gastroenterology. Guidelines on complications of gastrointestinal endoscopy. 2006. Available at: http://www.bsg.org.uk/clinical-guidelines. Accessed May 15, 2011.
28. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-8.
29. American Society for Gastrointestinal Endoscopy. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 2003;58:1-8.
30. Nelson DB. Infectious disease complications of GI endoscopy: Part I, endogenous infections. Gastrointest Endosc 2003;57:546-56.
31. Allison MC, Sandoe JA, Tighe R, et al. Antibiotic prophylaxis in gastrointestinal endoscopy. Gut 2009;58:869-80.
32. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-8.
33. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736-54.
34. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-8.
35. American Society for Gastrointestinal Endoscopy. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 2003;58:1-8.
36. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-8.
37. American Society for Gastrointestinal Endoscopy. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 2003;58:1-8.
38. ASGE Standards of Practice Committee; Tamir Ben-Menachem et. al. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012 Oct;76(4):707-18.
39. Newcomer MK, Brazer SR. Complications of upper gastrointestinal endoscopy and their management. Gastrointest.Endosc. Clin. N. Am. 1994;4(3):551–70.
40. Inoue H, Minami H, Kaga M, et al. Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest Endosc Clin N Am 2010;20:25-34.
41. Cao Y, Liao C, Tan A, et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009;41:751-7.
42. Inoue H, Minami H, Kaga M, et al. Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest Endosc Clin N Am 2010;20:25-34.
43. Cao Y, Liao C, Tan A, et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009;41:751-7.
44. Seewald S, Ang TL, Gotoda T, et al. Total endoscopic resection of Barrett esophagus. Endoscopy 2008;40:1016-20.
45. Muehldorfer SM, Stolte M, Martus P, et al. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut 2002;50:465-70.
46. Bardan E, Maor Y, Carter D, et al. Endoscopic ultrasound (EUS) before gastric polyp resection: is it mandatory? JClinGastroenterol 2007;41:371-4.
47. Hsieh YH, Lin HJ, Tseng GY, et al. Is submucosal epinephrine injection necessary before polypectomy? A prospective, comparative study. Hepatogastroenterology 2001;48:1379-82.
48. Lanza FL, Graham DY, Nelson RS, et al. Endoscopic upper gastrointestinal polypectomy. Report of 73 polypectomies in 63 patients. Am J Gastroenterol 1981;75:345-8.
49. Inoue H, Tani M, Nagai K, et al. Treatment of esophageal and gastric tumors. Endoscopy 1999;31(1):47–55.
50. Makuuchi H, Kise Y, Shimada H, Chino O, Tanaka H.Endoscopic mucosal resection for early gastric cancer. Semin. Surg. Oncol. 1999;17(2):108–16
51. Seewald S, Ang TL, Gotoda T, et al. Total endoscopic resection of Barrett esophagus. Endoscopy 2008;40:1016-20.
52. Ahmadi A, Draganov P. Endoscopic mucosal resection in the upper gastrointestinal tract. World J Gastroenterol 2008;14:1984-9.
53. Napoleon B, Gincul R, Ponchon T, Berthiller J, Escourrou J, Canard JM, et al. Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicenter prospective study. Endoscopy 2014;46(2):127e34.
54. Navaneethan U, Hasan MK, Lourdusamy V, Zhu X, Hawes RH, Varadarajulu S. Efficacy and safety of endoscopic mucosal resection of non-ampullary duodenal polyps: a systematic review. Endosc Int Open 2016;4(6): E699e708.
55. Probst A, Freund S, Neuhaus L. et al. Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas. Endoscopy 2020; 52: 847-855.
56. Abbass R, Rigaux J, Al-Kawas FH. Nonampullary duodenal polyps: characteristics and endoscopic management. Gastrointest Endosc 2010;71:754-9.
57. Johnson MD, Mackey R, Brown N, et al. Outcome based on management for duodenal adenomas: sporadic versus familial disease. J Gastrointest Surg 2010;14:229-35.
58. Lepilliez V, Chemaly M, Ponchon T, et al. Endoscopic resection of sporadic duodenal adenomas: an efficient technique with a substantial risk of delayed bleeding. Endoscopy 2008;40:806-10.
59. Klein A, Nayyar D, Bahin FF, Qi Z, Lee E, Williams SJ, et al. Endoscopic mucosal resection of large and giant lateral spreading lesions of the duodenum: success, adverse events, and long-term outcomes. Gastrointest Endosc 2016;84(4):688e96.
60. Navaneethan U, Hasan MK, Lourdusamy V. et al. Efficacy and safety of endoscopic mucosal resection of non-ampullary duodenal polyps: a systematic review. Endosc Int Open 2016; 4: E699-708.
61. Napoleon B, Gincul R, Ponchon T, Berthiller J, Escourrou J, Canard JM, et al. Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicenter prospective study. Endoscopy 2014;46(2):127e34.
62. Klein A, Nayyar D, Bahin FF, Qi Z, Lee E, Williams SJ, et al. Endoscopic mucosal resection of large and giant lateral spreading lesions of the duodenum: success, adverse events, and long-term outcomes. Gastrointest Endosc 2016;84(4):688e96.
63. Probst A, Freund S, Neuhaus L. et al. Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas. Endoscopy 2020; 52: 847-855.
64. Maruoka D, Matsumura T, Kasamatsu S. et al. Cold polypectomy for duodenal adenomas: a prospective clinical trial. Endoscopy 2017; 49: 776-783.
65. G. Vanbiervliet et al. Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021; 53(05): 522-534.
66. Choksi N, Elmunzer BJ, Stidham RW. et al. Cold snare piecemeal resection of colonic and duodenal polyps ≥1 cm. Endosc Int Open 2015; 3: E508-E513.
67. Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 2006;9:262-70.
68. Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J Gastroenterol 2008;14:2962-7.
69. Lian J, Chen S, Zhang Y et al. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc 2012; 76: 763-770.
70. Park YM, Cho E, Kang HY et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011; 25: 2666-2677.
71. Facciorusso A, Antonino M, Di Maso M et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis. World J Gastrointest Endosc 2014; 6: 555-563.
72. Na HK, Kim DH, Ahn JY. et al. Clinical outcomes following endoscopic treatment for sporadic nonampullary duodenal adenoma. Dig Dis 2020; 38: 364-372.
73. Esaki M, Haraguchi K, Akahoshi K. et al. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non-ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12: 918-930.
74. Yahagi N, Kato M, Ochiai Y. et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 2018; 88: 676-682.
75. Pérez-Cuadrado-Robles E, Quénéhervé L, Margos W. et al. Comparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumors. Endosc Int Open 2018; 6: E1008-E1014.
76. Hoteya S, Furuhata T, Takahito T. et al. Endoscopic submucosal dissection and endoscopic mucosal resection for non-ampullary superficial duodenal tumor. Digestion 2017; 95: 36-42.
77. Tamiya Y, Nakahara K, Kominato K, et al. Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection. Endoscopy 2010;42:8-14.
78. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57:1200-6.
79. Pouw RE, van Vilsteren FG, Peters FP, et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc 2011;74:35-43.
80. The Japanese Society for Esophageal Disease comprehensive registry of esophageal cancer in Japan, 2009. Esophagus. 2016;13:110–137.
81. Muehldorfer SM, Stolte M, Martus P, et al. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut 2002;50:465-70.
82. Bardan E, Maor Y, Carter D, et al. Endoscopic ultrasound (EUS) before gastric polyp resection: is it mandatory? JClinGastroenterol 2007;41:371-4.
83. Hsieh YH, Lin HJ, Tseng GY, et al. Is submucosal epinephrine injection necessary before polypectomy? A prospective, comparative study. Hepatogastroenterology 2001;48:1379-82.
84. Lanza FL, Graham DY, Nelson RS, et al. Endoscopic upper gastrointestinal polypectomy. Report of 73 polypectomies in 63 patients. Am J Gastroenterol 1981;75:345-8.
85. Ono H, Yao K, Fujishiro M et al. Guidelines for endoscopicsubmucosal dissection and endoscopic mucosal resection forearly gastric cancer. Dig. Endosc. 2016; 28:3–15.
86. Gotoda T. Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol. 2006 Sep;22(5):561-9.
87. Vanbiervliet G, Moss A, Arvanitakis M et al. Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021 May;53(5):522-534.
88. Probst A, Freund S, Neuhaus L. et al. Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas. Endoscopy 2020; 52: 847-855.
89. Abbass R, Rigaux J, Al-Kawas FH. Nonampullary duodenal polyps: characteristics and endoscopic management. Gastrointest Endosc 2010;71:754-9.
90. Johnson MD, Mackey R, Brown N, et al. Outcome based on management for duodenal adenomas: sporadic versus familial disease. J Gastrointest Surg 2010;14:229-35.
91. Lepilliez V, Chemaly M, Ponchon T, et al. Endoscopic resection of sporadic duodenal adenomas: an efficient technique with a substantial risk of delayed bleeding. Endoscopy 2008;40:806-10.
92. Pimentel-Nunes P. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015 Sep;47(9):829-54.
93. Yang D, Zou F, Xiong S, Forde JJ, Wang Y, Draganov PV. Endoscopic submucosal dissection for early Barrett’s neoplasia: a meta-analysis. Gastrointest. Endosc. 2018; 87: 1383–93.
94. Isomoto H, Yamaguchi N, Minami H, et al. Management of complications associated with endoscopic submucosal dissection/ endoscopic mucosal resection for esophageal cancer. Dig Endosc 2013;25 Suppl 1:29-38.
95. Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig. Dis. Sci. 2014; 59: 1862–9.
96. Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J Gastroenterol 2008;14:2962-7.
97. Lian J, Chen S, Zhang Y et al. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc 2012; 76: 763-770.
98. Park YM, Cho E, Kang HY et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011; 25: 2666-2677.
99. Facciorusso A, Antonino M, Di Maso M et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis. World J Gastrointest Endosc 2014; 6: 555-563.
100. Abe N, Gotoda T, Hirasawa T et al. Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older. Gastric Cancer 2012; 15: 70-75.
101. Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol 2006; 41: 929-942.
102. Lee DW, Jeon SW. Management of complications during gastric endoscopic submucosal dissection. Diagn Ther Endosc 2012; 2012: 624835.
103. Ono H, Yao K, Fujishiro M et al. Guidelines for endoscopicsubmucosal dissection and endoscopic mucosal resection forearly gastric cancer. Dig. Endosc. 2016; 28:3–15.
104. Yamamoto Y, Kikuchi D, Nagami Y et al. Management ofadverse events related to endoscopic resection of uppergastrointestinal neoplasms: Review of the literature and recom-mendations from experts. Dig. Endosc. 2019; 31(Suppl. 1): 4–20.
105. Vanbiervliet G, Moss A, Arvanitakis M et al. Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021 May;53(5):522-534.
106. Probst A, Freund S, Neuhaus L. et al. Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas. Endoscopy 2020; 52: 847-855.
107. Na HK, Kim DH, Ahn JY. et al. Clinical outcomes following endoscopic treatment for sporadic nonampullary duodenal adenoma. Dig Dis 2020; 38: 364-372.
108. Esaki M, Haraguchi K, Akahoshi K. et al. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non-ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12: 918-930.
109. Yahagi N, Kato M, Ochiai Y. et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 2018; 88: 676-682.
110. Pérez-Cuadrado-Robles E, Quénéhervé L, Margos W. et al. Comparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumors. Endosc Int Open 2018; 6: E1008-E1014.
111. Hoteya S, Furuhata T, Takahito T. et al. Endoscopic submucosal dissection and endoscopic mucosal resection for non-ampullary superficial duodenal tumor. Digestion 2017; 95: 36-42.
112. Nonaka S, Oda I, Tada K et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy 2015; 47: 129-135.
113. Abbass R, Rigaux J, Al-Kawas FH. Nonampullary duodenal polyps: characteristics and endoscopic management. Gastrointest Endosc 2010; 71: 754-759.
114. Alexander S, Bourke MJ, Williams SJ et al. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Gastrointest Endosc 2009; 69: 66-73.
115. Akahoshi K, Kubokawa M, Inamura K, Akahoshi K, Shiratsuchi Y, Tamura S. Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors. Curr Treat Options Oncol. 2020;21(12):98. Published 2020 Oct 26.
116. Inoue H, Tani M, Nagai K, et al. Treatment of esophageal and gastric tumors. Endoscopy 1999;31(1):47–55.
117. Makuuchi H, Kise Y, Shimada H, Chino O, Tanaka H.Endoscopic mucosal resection for early gastric cancer. Semin. Surg. Oncol. 1999;17(2):108–16
118. Pouw RE, van Vilsteren FG, Peters FP, et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc 2011;74:35-43.
119. The Japanese Society for Esophageal Disease comprehensive registry of esophageal cancer in Japan, 2009. Esophagus. 2016;13:110–137.
120. Inoue H, Tani M, Nagai K, et al. Treatment of esophageal and gastric tumors. Endoscopy 1999;31(1):47–55.
121. Makuuchi H, Kise Y, Shimada H, Chino O, Tanaka H.Endoscopic mucosal resection for early gastric cancer. Semin. Surg. Oncol. 1999;17(2):108–16
122. Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 2006;9:262-70.
123. Ono H, Yao K, Fujishiro M et al. Guidelines for endoscopicsubmucosal dissection and endoscopic mucosal resection forearly gastric cancer. Dig. Endosc. 2016; 28:3–15.
124. Vanbiervliet G, Moss A, Arvanitakis M et al. Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021 May;53(5):522-534.
125. Probst A, Freund S, Neuhaus L. et al. Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas. Endoscopy 2020; 52: 847-855.
126. Navaneethan U, Hasan MK, Lourdusamy V. et al. Efficacy and safety of endoscopic mucosal resection of non-ampullary duodenal polyps: a systematic review. Endosc Int Open 2016; 4: E699-708.
127. Napoleon B, Gincul R, Ponchon T, Berthiller J, Escourrou J, Canard JM, et al. Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicenter prospective study. Endoscopy 2014;46(2):127e34.
128. Klein A, Nayyar D, Bahin FF, Qi Z, Lee E, Williams SJ, et al. Endoscopic mucosal resection of large and giant lateral spreading lesions of the duodenum: success, adverse events, and long-term outcomes. Gastrointest Endosc 2016;84(4):688e96.
129. Yahagi N, Kato M, Ochiai Y. et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 2018; 88: 676-682
130. Pimentel-Nunes P. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015 Sep;47(9):829-54.
131. Yang D, Zou F, Xiong S, Forde JJ, Wang Y, Draganov PV. Endoscopic submucosal dissection for early Barrett’s neoplasia: a meta-analysis. Gastrointest. Endosc. 2018; 87: 1383–93.
132. Isomoto H, Yamaguchi N, Minami H, et al. Management of complications associated with endoscopic submucosal dissection/ endoscopic mucosal resection for esophageal cancer. Dig Endosc 2013;25 Suppl 1:29-38.
133. Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig. Dis. Sci. 2014; 59: 1862–9.
134. Noguchi M, Yano T, Kato T et al. Risk factors for intraoperative perforation during endoscopic submucosal dissection of superficial esophageal squamous cell carcinoma. World J. Gastroenterol. 2017; 23: 478–85.
135. Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J Gastroenterol 2008;14:2962-7.
136. Lian J, Chen S, Zhang Y et al. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc 2012; 76: 763-770.
137. Park YM, Cho E, Kang HY et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011; 25: 2666-2677.
138. Facciorusso A, Antonino M, Di Maso M et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis. World J Gastrointest Endosc 2014; 6: 555-563.
139. Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 2006;9:262-70.
140. Abe N, Gotoda T, Hirasawa T et al. Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older. Gastric Cancer 2012; 15: 70-75.
141. Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol 2006; 41: 929-942.
142. Lee DW, Jeon SW. Management of complications during gastric endoscopic submucosal dissection. Diagn Ther Endosc 2012; 2012: 624835.
143. Ono H, Yao K, Fujishiro M et al. Guidelines for endoscopicsubmucosal dissection and endoscopic mucosal resection forearly gastric cancer. Dig. Endosc. 2016; 28:3–15.
144. Yamamoto Y, Kikuchi D, Nagami Y et al. Management ofadverse events related to endoscopic resection of uppergastrointestinal neoplasms: Review of the literature and recom-mendations from experts. Dig. Endosc. 2019; 31(Suppl. 1): 4–20.
145. Vanbiervliet G, Moss A, Arvanitakis M et al. Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021 May;53(5):522-534.
146. Probst A, Freund S, Neuhaus L. et al. Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas. Endoscopy 2020; 52: 847-855.
147. Na HK, Kim DH, Ahn JY. et al. Clinical outcomes following endoscopic treatment for sporadic nonampullary duodenal adenoma. Dig Dis 2020; 38: 364-372.
148. Esaki M, Haraguchi K, Akahoshi K. et al. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non-ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12: 918-930.
149. Yahagi N, Kato M, Ochiai Y. et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 2018; 88: 676-682.
150. Pérez-Cuadrado-Robles E, Quénéhervé L, Margos W. et al. Comparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumors. Endosc Int Open 2018; 6: E1008-E1014.
151. Hoteya S, Furuhata T, Takahito T. et al. Endoscopic submucosal dissection and endoscopic mucosal resection for non-ampullary superficial duodenal tumor. Digestion 2017; 95: 36-42.
152. Nonaka S, Oda I, Tada K et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy 2015; 47: 129-135.
153. Abbass R, Rigaux J, Al-Kawas FH. Nonampullary duodenal polyps: characteristics and endoscopic management. Gastrointest Endosc 2010; 71: 754-759.
154. Alexander S, Bourke MJ, Williams SJ et al. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Gastrointest Endosc 2009; 69: 66-73.
155. Akahoshi K, Kubokawa M, Inamura K, Akahoshi K, Shiratsuchi Y, Tamura S. Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors. Curr Treat Options Oncol. 2020;21(12):98. Published 2020 Oct 26.
156. Seewald S, Ang TL, Gotoda T, et al. Total endoscopic resection of Barrett esophagus. Endoscopy 2008;40:1016-20.
157. Ahmadi A, Draganov P. Endoscopic mucosal resection in the upper gastrointestinal tract. World J Gastroenterol 2008;14:1984-9.
158. van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomized trial. Gut 2011;60:765–773.
159. Ning B, Abdelfatah MM, Othman MO. Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer. Ann. Cardiothorac. Surg. 2017; 6: 88–98.
160. Lewis JJ, Rubenstein JH, Singal AG, Elmunzer BJ, Kwon RS, Piraka CR. Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett’s esophagus. Gastrointest. Endosc. 2011; 74: 753–60.
161. The Japanese Society for Esophageal Disease comprehensive registry of esophageal cancer in Japan, 2009. Esophagus. 2016;13:110–137.
162. Navaneethan U, Hasan MK, Lourdusamy V. et al. Efficacy and safety of endoscopic mucosal resection of non-ampullary duodenal polyps: a systematic review. Endosc Int Open 2016; 4: E699-708.
163. Napoleon B, Gincul R, Ponchon T, Berthiller J, Escourrou J, Canard JM, et al. Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicenter prospective study. Endoscopy 2014;46(2):127e34.
164. Klein A, Nayyar D, Bahin FF, Qi Z, Lee E, Williams SJ, et al. Endoscopic mucosal resection of large and giant lateral spreading lesions of the duodenum: success, adverse events, and long-term outcomes. Gastrointest Endosc 2016;84(4):688e96.
165. Yang D, Zou F, Xiong S, Forde JJ, Wang Y, Draganov PV. Endoscopic submucosal dissection for early Barrett’s neoplasia: a meta-analysis. Gastrointest. Endosc. 2018; 87: 1383–93.
166. Isomoto H, Yamaguchi N, Minami H, et al. Management of complications associated with endoscopic submucosal dissection/ endoscopic mucosal resection for esophageal cancer. Dig Endosc 2013;25 Suppl 1:29-38.
167. Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig. Dis. Sci. 2014; 59: 1862–9.
168. Shi Q, Ju H, Yao LQ et al. Risk factors for postoperative stricture after endoscopic submucosal dissection for superficial esophageal carcinoma. Endoscopy 2014; 46: 640–4
169. Tsunada S, Ogata S, Mannen K et al. Case series of endoscopic balloon dilation to treat a stricture caused by circumferential resection of the gastric antrum by endoscopic submucosal dissection. Gastrointest. Endosc. 2008; 67: 979–83.
170. Coda S, Oda I, Gotoda T, Yokoi C, Kikuchi T, Ono H. Risk factors for cardiac and pyloric stenosis after endoscopic submucosal dissection, and efficacy of endoscopic balloon dilation treatment. Endoscopy 2009; 41: 421–6.
171. Iizuka H, Kakizaki S, Sohara N et al. Stricture after endoscopic submucosal dissection for early gastric cancers and adenomas. Dig. Endosc. 2010; 22: 282–8.
172. Sumiyoshi, T., Kondo, H., Minagawa, T. et al. Risk factors and management for gastric stenosis after endoscopic submucosal dissection for gastric epithelial neoplasm. Gastric Cancer 20, 690–698 (2017).
173. Luman W., Lessels A.M.,Palmer K.R. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.Eur J Gastroenterol Hepatol. 1996; 8: 627-630.
174. Sampliner R.E., Faigel D., Fennerty M.B.et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc. 2001; 53: 554-558.
175. Dulai G.S., Jensen D.M., Cortina G. et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005; 61: 232-240.
176. Rees J.R., Lao-Sirieix P., Wong A. et al. Treatment for Barrett's oesophagus. Cochrane Database Syst Rev. 2010.
177. Manner H., May A., Miehlke S. et al. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol. 2006; 101: 1762-1769.
178. Rösch T., Manner H., May A. Multicenter feasibility study of combined injection and argon plasma coagulation (hybrid-APC) in the ablation therapy of neoplastic Barrett esophagus [abstract] Gastrointest Endosc. 2018;87.
179. Manner H., May A., Kouti I. Efficacy and safety of hybrid-APC for the ablation of Barrett's esophagus. Surg Endosc. 2016;30:1364–1370.
180. Rösch T., Manner H., May A. Multicenter feasibility study of combined injection and argon plasma coagulation (hybrid-APC) in the ablation therapy of neoplastic Barrett esophagus [abstract] Gastrointest Endosc. 2018;87.
181. Shimizu T., Samarasena J.B., Fortinsky K.J. Efficacy, tolerance, and safety of hybrid argon plasma coagulation for the treatment of Barrett’s esophagus: a single center pilot study [abstract] Gastrointest Endosc. 2018;87:AB292.
182. S Kashin, N Vidyaeva, R Kuvaev, E Kraynova,H Manner. Hybrid-APC for the endoscopic eradication of dysplastic Barrett’s esophagus in a low prevalence country: long-term results of the treatment after the onsite training. Endoscopy 2019; 51(04): S238.
183. Qumseya B.J., Wani S., Desai M. et al. Adverse events after radiofrequency ablation in patients with barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016; 14: 1086-1095.e6.
184. Pouw R.E., Gondrie J.J., Van Vilsteren F.G.I. et al. Complications following circumferential radiofrequency energy ablation of Barrett's esophagus containing early neoplasia. Gastrointest Endosc. 2008; 67: AB145
185. Shaheen N.J., Sharma P., Overholt B.F. et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360: 2277-2288.
186. Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc. 2009; 23: 2175-2180.
187. Lyday W.D., Corbett F.S., Kuperman D.A. et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010; 42: 272-278.
188. Pouw R.E., Gondrie J.J., Van Vilsteren F.G.I. et al. Complications following circumferential radiofrequency energy ablation of Barrett's esophagus containing early neoplasia. Gastrointest Endosc. 2008; 67: AB145
189. S. N. van Munster, J. Bergman, Roos E. Pouw. Systematic review for cryoablation of Barrett’s esophagus: Can we draw conclusions by combining apples, oranges and a banana? CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(03): E465-E466.
190. Greenwald B.D., Dumot J.A., Abrams J.A. et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc. 2010; 71: 686-693.
191. Shaheen N.J., Greenwald B.D., Peery A.F. et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 2010; 71: 680-685.
192. Greenwald B.D., Dumot J.A., Horwhat J.D. et al. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus. 2010; 23: 13-19.
193. Gregori D, Scarinzi C, Morra B, et al. Ingested foreign bodies causing complications and requiring hospitalization in European children: results from the ESFBI study. Pediatr Int 2010;52:26-32.
194. Palta R, Sahota A, Bemarki A, et al. Foreign-body ingestion: characteristics and outcomes in a lower socioeconomic population with predominantly intentional ingestion. Gastrointest Endosc 2009;69:426-33.
195. Berggreen PJ, Harrison E, Sanowski RA, Ingebo K, Noland B, Zierer S. Techniques and complications of esophageal foreign body extraction in children and adults. Gastrointest.Endosc. 1993;39(5):626–30.
196. Arms JL, Mackenberg-Mohn MD, Bowen MV, et al. Safety and efficacy of a protocol using bougienage or endoscopy for the management of coins acutely lodged in the esophagus: a large case series. Ann Emerg Med 2008;51:367-72.
197. Cheng W, Tam PK. Foreign-body ingestion in children: experience with 1,265 cases. J Pediatr Surg 1999;34:1472-6.
198. Li ZS, Sun ZX, Zou DW, et al. Endoscopic management of foreign bodies in the upper-GI tract: experience with 1088 cases in China. Gastrointest Endosc 2006;64:485-92.
199. Lin HH, Lee SC, Chu HC, et al. Emergency endoscopic management of dietary foreign bodies in the esophagus. Am J Emerg Med 2007;25:662-5.
200. Longstreth GF, Longstreth KJ, Yao JF. Esophageal food impaction: epidemiology and therapy. A retrospective, observational study. Gastrointest Endosc 2001;53:193-8.
201. Mosca S, Manes G, Martino R, et al. Endoscopic management of foreign bodies in the upper gastrointestinal tract: report on a series of 414 adult patients. Endoscopy 2001;33:692-6.
202. Vicari JJ, Johanson JF, Frakes JT. Outcomes of acute esophageal food impaction: success of the push technique. Gastrointest Endosc 2001; 53:178-81.
203. Zhang S, Cui Y, Gong X, et al. Endoscopic management of foreign bodies in the upper gastrointestinal tract in South China: a retrospective study of 561 cases. Dig Dis Sci 2010;55:1305-12.
204. Ginsberg GG. Management of ingested foreign objects and food bolus impactions. Gastrointest Endosc 1995;41:33-8.
205. Dark DS, Campbell DR, Wesselius LJ. Arterial oxygen desaturation during gastrointestinal endoscopy. Am. J. Gastroenterol. 1990;85(10):1317–21.
206. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992;102:139-48.
207. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009;7:33-47.
208. Sung JJ, Tsoi KK, Ma TK, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010;105:84-9.
209. Lee KJ, Kim JH, Hahm KB, et al. Randomized trial of N-butyl-2-cyanoacrylate compared with injection of hypertonic salineepinephrine in the endoscopic treatment of bleeding peptic ulcers. Endoscopy 2000;32:505-11.
210. Scharnke W, Hust MH, Braun B, et al. Complete gastric wall necrosis after endoscopic sclerotherapy for a gastric ulcer with visible arterial stump [in German]. Dtsch Med Wochenschr 1997;122:606-9.
211. Choudari CP, Palmer KR. Endoscopic injection therapy for bleeding peptic ulcer; a comparison of adrenaline alone with adrenaline plus ethanolamine oleate. Gut 1994;35:608-10
212. Lin HJ, Tseng GY, Perng CL, Lee FY, Chang FY, Lee SD. Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut 1999;44(5):715–19.
213. Chung SS, Lau JY, Sung JJ, et al. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 1997;314:1307-11.
214. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007;102:279-89; quiz 469.
215. Rutgeerts P, Vantrappen G, Van Hootegem P, et al. Neodymium-YAG laser photocoagulation versus multipolar electrocoagulation for the treatment of severely bleeding ulcers: a randomized comparison. Gastrointest Endosc 1987;33:199-202.
216. Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 2007;56:1364-73.
217. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N. Engl. J.Med. 1999;340(10):751–6
218. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009;7:33-47.
219. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007;102:279-89; quiz 469.
220. Laine L. Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. A prospective controlled trial. N Engl J Med 1987;316:1613-7.
221. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009;7:33-47.
222. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007;102:279-89; quiz 469.
223. Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injection and thermo‐coagulation in the treatment of non‐variceal upper gastrointestinal bleeding: a meta‐analysis. Gut 2007;56:1364–73
224. Kapetanos D, BeltsisA,ChatzimavroudisG, et al. The use of endoclips in the treatment of nonvariceal gastrointestinal bleeding. Surg Laparosc
Endosc Percutan Tech 2009;19:2-10.
225. Laine L., Cook D.Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding A meta-analysis. Ann Intern Med. 1995; 123: 280-287.
226. Schuman B.M., Beckman J.W., Tedesco F.J. et al. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol. 1987; 82: 823-830.
227. Piai G., Cipolletta L., Claar M. et al. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology. 1988; 8: 1495-1500.
228. Sarin S.K., Nanda R., Sachdev G. et al. Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut. 1987; 28: 657-662.
229. Sarin S.K., Sachdev G., Nanda R. et al.Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut. 1986; 27: 710-713.
230. Westaby D., Melia W.M., Macdougall B.R. et al. Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules. Gut. 1984; 25: 129-132.
231. Tamura S., Shiozaki H., Kobayashi K. et al. Prospective randomized study on the effect of ranitidine against injection ulcer after endoscopic injection sclerotherapy for esophageal varices. Am J Gastroenterol. 1991; 86: 477-480.
232. Polson R.J., Westaby D., Gimson A.E. et al. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology. 1989; 10: 279-282.
233. Tabibian N., Smith J.L., Graham D.Y. Sclerotherapy-associated esophageal ulcers: lessons from a double-blind, randomized comparison of sucralfate suspension versus placebo. Gastrointest Endosc. 1989; 35: 312-315.
234. Piai G., Cipolletta L., Claar M. et al. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology. 1988; 8: 1495-1500.
235. Krige J.E., Shaw J.M., Bornman P.C. et al. Early rebleeding and death at 6 weeks in alcoholic cirrhotic patients with acute variceal bleeding treated with emergency endoscopic injection sclerotherapy. S Afr J Surg. 2009; 47: 72-74.
236. Yuki M., Kazumori H., Yamamoto S. et al. Prognosis following endoscopic injection sclerotherapy for esophageal varices in adults: 20-year follow-up study. Scand J Gastroenterol. 2008; 43: 1269-1274.
237. Krige J.E., Bornman P.C., Shaw J.M. et al. Complications of endoscopic variceal therapy. S Afr J Surg. 2005; 43: 177-188.
238. Schmitz R.J., Sharma P., Badr A.S. et al. Incidence and management of esophageal stricture formation, ulcer bleeding, perforation, and massive hematoma formation from sclerotherapy versus band ligation. Am J Gastroenterol. 2001; 96: 437-441.
239. Koch H., Henning H., Grimm H. et al. Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. Endoscopy. 1986; 18: 40-43.
240. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A. et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992; 326: 1527-1532.
241. Sorensen T., Burcharth F., Pedersen M.L. et al. Oesophageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices. Gut. 1984; 25: 473-477.
242. Schmitz R.J., Sharma P., Badr A.S. et al. Incidence and management of esophageal stricture formation, ulcer bleeding, perforation, and massive hematoma formation from sclerotherapy versus band ligation. Am J Gastroenterol. 2001; 96: 437-441.
243. The Copenhagen Esophageal Varices Sclerotherapy Project. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med. 1984; 311: 1594-1600.
244. Korula J., Pandya K., Yamada S. et al. Perforation of esophagus after endoscopic variceal sclerotherapy Incidence and clues to pathogenesis. Dig Dis Sci. 1989; 34: 324-329.
245. Elfant A.B., Peikin S.R., Alexander J.B. et al.Conservative management of endoscopic sclerotherapy-induced esophageal perforation. Am Surg. 1994; 60: 985-987.
246. Korula J., Pandya K., Yamada S. et al. Perforation of esophagus after endoscopic variceal sclerotherapy Incidence and clues to pathogenesis. Dig Dis Sci. 1989; 34: 324-329.
247. Iwase H., Suga S., Shimada M. et al. Eleven-year survey of safety and efficacy of endoscopic injection sclerotherapy using 2% sodium tetradecyl sulfate and contrast medium. J Clin Gastroenterol. 1996; 22: 58-65.
248. Laine L., el-Newihi H.M., Migikovsky B. et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993; 119: 1-7.
249. Deboever G., Elegeert I., Defloor E. Portal and mesenteric venous thrombosis after endoscopic injection sclerotherapy. Am J Gastroenterol. 1989; 84: 1336-1337.
250. Stoltenberg P.H., Goodale R.L., Silvis S.E.Portal vein thrombosis following combined endoscopic variceal sclerosis and vasopressin therapy for bleeding varices. Am J Gastroenterol. 1987; 82: 1297-1300.
251. Alexander S., Korman M.G., Sievert W. Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli. Intern Med J. 2006; 36: 462-465.
252. Neumann H., Scheidbach H., Mönkemüller K. et al. Multiple cyanoacrylate (Histoacryl) emboli after injection therapy of cardia varices. Gastrointest Endosc. 2009; 70: 1025-1026.
253. Garcia-Tsao G., Sanyal A.J., Grace N.D. et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46: 922-938.
254. Rerknimitr R., Chanyaswad J., Kongkam P. et al. Risk of bacteremia in bleeding and nonbleeding gastric varices after endoscopic injection of cyanoacrylate. Endoscopy. 2008; 40: 644-649.
255. Sauerbruch T., Holl J., Ruckdeschel G. et al. Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy. 1985; 17: 170-172.
256. Banerjee S., Shen B., Baron T.H. et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008; 67: 791-798
257. Laine L., Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med. 1995; 123: 280-287.
258. Lo G.H., Lai K.H., Cheng J.S. et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995; 22: 466-471.
259. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A. et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992; 326: 1527-1532.
260. Young M.F., Sanowski R.A., Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc. 1993; 39: 119-122.
261. Shaheen N.J., Stuart E., Schmitz S.M. et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005; 41: 588-594.
262. Laine L., el-Newihi H.M., Migikovsky B. et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993; 119: 1-7.
263. Lo G.H., Lai K.H., Cheng J.S. et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995; 22: 466-471.
264. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A. et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992; 326: 1527-1532.
265. Laine L., el-Newihi H.M., Migikovsky B. et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993; 119: 1-7.
266. Lo G.H., Lai K.H., Cheng J.S. et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995; 22: 466-471.
267. Young M.F., Sanowski R.A., Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc. 1993; 39: 119-122.
268. Rai R.R., Nijhawan S., Singh G. Post-ligation stricture: a rare complication. Endoscopy. 1996; 28: 406.
269. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A. et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992; 326: 1527-1532.
270. Laine L., el-Newihi H.M., Migikovsky B. et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993; 119: 1-7.
271. Lo G.H., Lai K.H., Cheng J.S. et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995; 22: 466-471.
272. Young M.F., Sanowski R.A., Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc. 1993; 39: 119-122.
273. Mandelstam P, Sugawa C, Silvis SE, et al. Complications associated with esophagogastroduodenoscopy and with esophageal dilation. Gastrointest. Endosc. 976;23(1):16–19.
274. Saeed ZA, Winchester CB, Ferro PS, Michaletz PA, Schwartz JT, Graham DY. Prospective randomized comparison of polyvinyl bougies and through‐the‐scope balloon for dilation of peptic strictures of the esophagus. Gastrointest. Endosc. 1995;41(3):189–95.
275. Scolapio JS, Pasha TM, Gostout CJ, et al. A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings. Gastrointest. Endosc. 1999;50:13–17.
276. Kozarek RA. Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey. Gastrointest. Endosc.1986;32(1):15–19.
277. Karnak I, Tanyel FC, Buyukpamukcu N, Hicsonmez A. Esophageal perforations encountered during dilation ofcaustic esophageal strictures. J. Cardiovasc. Surg. 1998;39(3):373–7.
278. Kim GH, Jung KW, Jung HY, Kim MJ, Na HK, Ahn JY, et al. Superior clinical outcomes of peroral endoscopic myotomy compared with balloon dilation in all achalasia subtypes. J Gastroenterol Hepatol 2019;34:659–665
279. Nair LA, Reynolds JC, Parkman HP, et al. Complications during pneumatic dilation for achalasia or diffuse esophageal spasm. Analysis of risk factors, early clinical characteristics, and outcome. Dig. Dis. Sci. 1993;38(10):1893–904.
280. Newcomer MK, Brazer SR. Complications of upper gastrointestinal endoscopy and their management. Gastrointest. Endosc. Clin. N. Am. 1994;4(3):551–70.
281. Ng TM, Spencer GM, Sargeant IR, Thorpe SM, Brown SG. Management of strictures after radiotherapy for esophageal cancer. Gastrointest. Endosc. 1996;43(6):584–90.
282. Botoman VA, Surawicz CM. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest. Endosc. 1986;32(5):342–6.
283. Disario JA, Fennerty MB, Tietze CC, Hutson WR, Burt RW. Endoscopic balloon dilation for ulcer‐induced gastric outlet obstruction. Am. J. Gastroenterol. 1994;89(6):868–71
284. Lau JY, Chung SC, Sung JJ, et al. Through‐the‐scope balloon dilation for pyloric stenosis: long‐term results. Gastrointest. Endosc. 1996;43:98–101.
285. Manon C. W. et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021. Published online: 30.4.2021 Endoscopy 2021; 53
286. Shenfine J, McNamee P, Steen N, et al. A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol 2009;104:1674-85
287. Jacobson BC, Hirota W, Baron TH, et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003;57:817-22.
288. Kozarek RA, Ball TJ, Patterson DJ. Metallic self-expanding stent application in the upper gastrointestinal tract: caveats and concerns. Gastrointest Endosc 1992;38:1-6
289. Tierney W, Chuttani R, Croffie J, et al. Enteral stents. Gastrointest Endosc 2006;63:920-6.
290. Baron TH. A practical guide for choosing an expandable metal stent for GI malignancies: is a stent by any other name still a stent? Gastrointest Endosc 2001;54:269-72.
291. Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am 2007;17:83-104.
292. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001;344:1681-7.
293. Siersema PD, Hop WC, van Blankenstein M, et al. A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. Gastrointest Endosc 2000;51:139-45.
294. Vleggaar FP, Siersema PD. Expandable stents for malignant esophageal disease. Gastrointest Endosc Clin N Am 2011;21:377-88.
295. Dua KS, Kozarek R, Kim J, et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 2001;53:603-13.
296. Homs MY, Wahab PJ, Kuipers EJ, et al. Esophageal stentswith antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc 2004;60:695-702.
297. Schembre DB. Recent advances in the use of stents for esophageal disease. Gastrointest Endosc Clin N Am 2010;20:103-21.
298. Tierney W, Chuttani R, Croffie J, et al. Enteral stents. Gastrointest Endosc 2006;63:920-6.
299. Homs MY, Steyerberg EW, Kuipers EJ, et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 2004;36:880-6.
300. Tierney W, Chuttani R, Croffie J, et al. Enteral stents. Gastrointest Endosc 2006;63:920-6.
301. Wang MQ, Sze DY, Wang ZP, et al. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. JVasc IntervRadiol 2001;12:465-74.
302. Kinsman KJ, DeGregorio BT, Katon RM, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 1996;43:196-203.
303. Gaidos JK, Draganov PV. Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World J Gastroenterol 2009;15:4365-71.
304. Gaidos JK, Draganov PV. Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World J Gastroenterol 2009;15:4365-71.
305. Maetani I,Ukita T, Tada T, et al. Metallic stents for gastric outlet obstruction: reintervention rate is lower with uncovered versus covered stents, despite similar outcomes. Gastrointest Endosc 2009;69:806-12.
306. Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010;71:490-9.
307. Ly J, O’Grady G, Mittal A, et al. A systematic review of methods to palliate malignant gastric outlet obstruction. Surg Endosc 2010;24:290-7.
308. Inoue H, Minami H, Kobayashi Y. et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42: 265-271.
309. Zhang X, Li Q, Xu M. et al. Major perioperative adverse events of peroral endoscopic myotomy : a systematic 5-year analysis. Endoscopy 2016; 48: 967-978.
310. Wang X, Tan Y, Lv L, Zhu H, Chu Y, Li C, Liu D. Peroral endoscopic myotomy versus pneumatic dilation for achalasia in patients aged ≥ 65 years. Rev Esp Enferm Dig 2016; 108:637–641.
311. Tan Y, Zhu H, Li C, Chu Y, Huo J, Liu D. Comparison of peroral endoscopic myotomy and endoscopic balloon dilation for primary treatment of pediatric achalasia. J Pediatr Surg 2016; 51:1613–1618.
312. Meng F, Li P, Wang Y, Ji M, Wu Y, Yu L, et al. Peroral endoscopic myotomy compared with pneumatic dilation for newly diagnosed achalasia. Surg Endosc 2017; 31:4665–4672.
313. Zhong C. et al. Peroral endoscopic myotomy versus pneumatic dilation for achalasia: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020 Nov;32(11):1413-1421.
314. Tan Y, Zhu H, Li C, Chu Y, Huo J, Liu D. Comparison of peroral endoscopic myotomy and endoscopic balloon dilation for primary treatment of pediatric achalasia. J Pediatr Surg 2016; 51:1613–1618.
315. Meng F, Li P, Wang Y, Ji M, Wu Y, Yu L, et al. Peroral endoscopic myotomy compared with pneumatic dilation for newly diagnosed achalasia. Surg Endosc 2017; 31:4665–4672.
316. Wang X, Tan Y, Lv L, Zhu H, Chu Y, Li C, Liu D. Peroral endoscopic myotomy versus pneumatic dilation for achalasia in patients aged ≥ 65 years. Rev Esp Enferm Dig 2016; 108:637–641.
317. Ponds FA, Fockens P, Lei A, Neuhaus H, Beyna T, Kandler J, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA 2019; 322:134–144
318. Zheng Z, Zhao C, Su S, Fan X, Zhao W, Wang B, et al. Peroral endoscopic myotomy versus pneumatic dilation - result from a retrospective study with 1-year follow-up. Z Gastroenterol 2019; 57:304–311.
319. Kim GH, Jung KW, Jung HY, Kim MJ, Na HK, Ahn JY, et al. Superior clinical outcomes of peroral endoscopic myotomy compared with balloon dilation in all achalasia subtypes. J Gastroenterol Hepatol 2019;34:659–665.
320. I Kanischev, I Nedoluzhko, K Shishin, N Kurushkina,L Shumkina. Poem as a Treatment Option For Achalasia In Patients 65 Years of Age and Older. Endoscopy 2021; 53(S 01): S109.
321. Bas L A M Weusten et al. Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020 Jun;52(6):498-515.
322. Zhang X, Li Q, Xu M. et al. Major perioperative adverse events of peroral endoscopic myotomy : a systematic 5-year analysis. Endoscopy 2016; 48: 967-978.
323. Bayer J, Vackova Z, Svecova H. et al. Gentamicin submucosal lavage during peroral endoscopic myotomy (POEM): a retrospective analysis. Surg Endosc 2018; 32: 300-306.
324. Bas L A M Weusten et al. Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020 Jun;52(6):498-515.
325. Costamagna G, Iacopini F, Bizzotto A, et al. Prognostic variables for the clinical success of flexible endoscopic septotomy of Zenker's diverticulum. Gastrointest Endosc 2016; 83(4): 765-773.
326. Shahawy S, Janisiewicz AM, Annino D. et al. A comparative study of outcomes for endoscopic diverticulotomy versus external diverticulectomy. Otolaryngol Head Neck Surg 2014; 151: 646-651.
327. Verdonck J, Morton RP. Systematic review on treatment of Zenker’s diverticulum. Eur Arch Otorhinolaryngol 2015; 272: 3095-3107.
328. Albers D, Kondo A, Bernardo W. et al. Endoscopic versus surgical approach in the treatment of Zenker’s diverticulum: systematic review and meta-analysis. Endosc Int Open 2016; 04: E678-E686.
329. Ishaq S, Hassan C, Antonello A. et al. Flexible endoscopic treatment for Zenker’s diverticulum: A systematic review and meta-analysis. Gastrointest Endosc 2016; 83: 1076-1089.e5.
330. Yang J, Novak S, Ujiki M. et al. An international study on the use of peroral endoscopic myotomy in the management of Zenker’s diverticulum. Gastrointest Endosc 2020; 91: 163-168.
331. Pavlov I, Shishin K, Nedoluzhko I et al. eP32 Results of the Endoscopic Treatment of Patients With Zenker’s Diverticulum. Endoscopy 2021; 53: S107.
332. Verdonck J, Morton RP. Systematic review on treatment of Zenker’s diverticulum. Eur Arch Otorhinolaryngol 2015; 272: 3095-3107.
333. Bas L A M Weusten et al. Endoscopic management of gastrointestinal motility disorders - part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020 Jul;52(7):600-614.
334. Ishaq S, Hassan C, Antonello A. et al. Flexible endoscopic treatment for Zenker’s diverticulum: A systematic review and meta-analysis. Gastrointest Endosc 2016; 83: 1076-1089.e5.
335. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P. Endoscopic complications. Results of the 1974 American Society of Gastrointestinal Endoscopy Survey. JAMA 1976; 235(9):928–30.
336. Newcomer MK, Brazer SR. Complications of upper gastrointestinal endoscopy and their management. Gastrointest.Endosc. Clin. N. Am. 1994;4(3):551–70.

.



Открыт общий доступ к полному тексту статьи свернуть
05.02.24 ©
Оцените материал: Рейтинг: 10

Комментарии

Написать

При эндоскопическом исследовании в случае бронхоэктазов в стадии ремиссии выявляется

частично диффузный бронхит I степени воспаления

Работаем и учимся при поддержке

Партнеры